Illumineuro Blend is a 50mg four-component research blend containing N-Acetyl Semax 20mg, N-Acetyl Selank 10mg, Pinealon 10mg and PE-22-28 10mg. It is supplied as a single lyophilised material for controlled laboratory research.
Research blend only
This material is not supplied as a medicine, treatment, cosmetic, supplement or consumer product. It is not for human or veterinary use, consumption or administration, and is not intended to diagnose, treat, cure or prevent any disease.
Blend overview
Product typeFour-component research blend
N-Acetyl Semax20mg
N-Acetyl Selank10mg
Pinealon10mg
PE-22-2810mg
Total nominal content50mg
FormLyophilised blend
Research context
Component-level literature includes analytical characterisation of N-acetylated Semax and Selank, cellular oxidative-stress studies of Pinealon, and preclinical TREK-1 channel studies of PE-22-28. These are different lines of research, not evidence of a shared or synergistic effect in this blend.
No published study of this exact four-component formulation is cited. Findings for unmodified Semax or Selank must not be assumed to apply to their N-acetyl derivatives. See the Research tab for the sources and evidence limitations.
Batch documentation
Independent analytical documentation is published where available for specific batches and variations. A result indicator appears only when a published record is available. Match the product, stated composition and batch identifier to the corresponding report before relying on any result.
View available Illumineuro Blend lab results →
Supply and laboratory handling
- Supplied as a single vial containing the component amounts stated above.
- Keep the sealed lyophilised vial dry and protected from direct light.
- A cool, dry place, refrigerator or freezer may be used according to the intended storage duration, component-specific information and your laboratory’s validated procedure.
- Use clean laboratory technique and equipment appropriate to the intended analytical method.
- Follow the lot-specific documentation and your laboratory’s validated handling and storage procedures.
- Avoid repeated temperature cycling and unnecessary exposure to moisture.
Where a batch document or supplier specification gives different instructions, the lot-specific document takes precedence.
Frequently asked questions
What does Illumineuro Blend contain?
Each 50mg vial is labelled as containing N-Acetyl Semax 20mg, N-Acetyl Selank 10mg, Pinealon 10mg and PE-22-28 10mg.
Has this exact blend been studied?
The references provided in the Research tab concern the individual named components or related research material. No published study of this exact four-component formulation is cited, and component findings should not be assumed to describe the combined blend.
Which vial sizes are available?
Current vial sizes, stock, pre-order status, pricing and any batch-documentation indicators are shown in the variation selector above.
Does every batch have a published laboratory result?
No. Results are available only for the selected batches marked with a result indicator. Always check that the product, composition and batch identifier match the report.
How should the material be stored?
Keep the sealed lyophilised blend dry and protected from light. A cool, dry place, refrigerator or freezer may be used according to the intended storage duration, component-specific information and your laboratory’s validated procedure. Avoid repeated temperature cycling and moisture exposure. No universal shelf-life is stated unless it is supported by batch documentation.
Information reviewed: 18 October 2026.
Batch-specific analytical documentation
Independent analytical results are published for selected Havoc Labs products, vial sizes and batches. The result attached to one variation must not be treated as evidence for a different size or batch.
- Result available: a published report is available for the marked variation.
- Test pending: a sample has been submitted, but no completed result is being claimed.
- No indicator: no product-specific result is currently displayed for that variation.
Check the identifiers
Always match the compound, vial size and batch reference on the product to the corresponding laboratory record. Where the laboratory provides an independent verification facility, use it to confirm the report.
Browse published lab results →
Storage and stability
Storage requirements can vary by compound, physical form, intended storage duration and batch. Follow the lot-specific documentation and your laboratory’s validated procedure wherever these are available.
| Form |
Suggested storage |
Important note |
| Sealed lyophilised material |
Keep in a cool, dry place, refrigerated at 2–8°C or frozen, as appropriate for the compound and intended storage period. |
Keep sealed, dry and protected from direct light. Follow compound- and batch-specific documentation and avoid repeated temperature cycling. |
| Reconstituted solution |
Refrigerate at 2–8°C unless the applicable laboratory protocol specifies otherwise. |
Stability depends on the preparation conditions, solvent, concentration, container and handling. No universal storage period is claimed. |
No universal shelf-life is claimed
Do not assume a fixed expiry or prepared-solution storage period unless it is supported by relevant stability data or batch documentation. Where a lot-specific document gives different instructions, that document takes precedence.
Illumineuro Blend: component research
The references concern individual components or analytical reference materials. No published study of this exact 20mg / 10mg / 10mg / 10mg combination is cited. Component findings do not establish blend interactions, stability, synergy or clinical benefit.
- N-Acetyl Semax and N-Acetyl Selank — analytical identification. Vanhee C et al. The occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: An incentive for controlling agencies to prepare for future encounters of the kind. Drug Testing and Analysis, 2020. This analytical study reports chromatographic and mass-spectrometric characterisation of the acetylated peptides and distinguishes them from their parent and amidated forms. It is not an efficacy or safety study. View publication ↗
- Pinealon — cell models. Khavinson V et al. Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes. Rejuvenation Research, 2011. Examined reactive oxygen species, cell death and signalling in experimental cell systems. View on PubMed ↗
- PE-22-28 — preclinical channel and behavioural research. Djillani A et al. Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity. Frontiers in Pharmacology, 2017. Investigated TREK-1 inhibition in engineered cells and behavioural and neuronal endpoints in mouse models. Animal antidepressant-like findings do not establish antidepressant efficacy in people. View on PubMed ↗
Evidence limitations
Studies of standard Semax and Selank do not verify the effects of their N-acetyl derivatives. The cited work does not establish human safety or efficacy for this formulation and does not verify the identity, content or purity of a supplied batch. Match the stated composition to lot-specific analytical documentation. Research use only; not for human or veterinary use.
References reviewed 18 October 2026.
